Skip to main content


A top cancer research team from the Icahn School of Medicine at Mount Sinai Hospital in New York have joined Houston Methodist.

Shu-Hsia Chen, a cancer immunotherapy researcher, and her team of 10 are now at Houston Methodist. In doing so, they will form the Center for Immunotherapy Research, which will focus on expanding cancer immunotherapy research at Houston Methodist, according to a statement.

Chen's research has focused on identifying immune suppressive cells in cancer patients, which cause inflammatory conditions in cancer patients, and then reprogramming those cells to treat cancer and chronic inflammatory diseases, the statement said.